Goodwill and Intangible Assets

12 Months Ended

Dec. 31, 2020

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill and Intangible Assets

Goodwill and Intangible Assets 

The Company’s amortizable and unamortizable intangible assets at December 31, 2020 and 2019, respectively, are as follows: 

	2020						2019
Goodwill and Intangible Assets:	Gross Value		Accumulated Amortization		Net Carrying Amount		Gross Value		Accumulated Amortization		Net Carrying Amount
Acquired developed technology - Vazculep (1)	$	—	$	—	$	—	$	12,061	$	(11,248)	$	813
Unamortizable intangible assets - Goodwill (2)	$	16,836	$	—	$	16,836	$	18,491	$	—	$	18,491

(1) This intangible asset was assumed by the Exela Buyer as part of the disposition of the Hospital Products on June 30, 2020. See Note 4: Disposition of the Hospital Products.

(2) In connection with the disposition of the Hospital Products (see Note 4: Disposition of the Hospital Products), the Company allocated goodwill of $1,655 on a relative fair value basis to the Hospital Products and included this amount in the net gain on the disposition of the Hospital Products on the consolidated statement of income (loss) during the year ended December 31, 2020.

The Company recorded amortization expense related to amortizable intangible assets of $406, $816 and $6,619 for the years ended December 31, 2020, 2019 and 2018, respectively.  

No impairment loss related to goodwill or intangible assets was recognized during the years ended December 31, 2020 or 2019.